Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses
出版年份 2017 全文链接
标题
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses
作者
关键词
-
出版物
OncoImmunology
Volume 6, Issue 9, Pages e1339855
出版商
Informa UK Limited
发表日期
2017-08-18
DOI
10.1080/2162402x.2017.1339855
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8 + T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells
- (2016) Jordana G. Coelho-dos-Reis et al. CLINICAL IMMUNOLOGY
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
- (2016) A. L. Silva et al. Human Vaccines & Immunotherapeutics
- Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
- (2016) Shuichi Kitayama et al. Stem Cell Reports
- Co-operation of -galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
- (2015) T. Dong et al. BIOCHEMICAL JOURNAL
- Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8 + T-cell responses and prevent tumour progression
- (2015) Silke Neumann et al. VACCINE
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
- (2014) Gianfranco Picco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
- (2014) Duygu Sag et al. JOURNAL OF CLINICAL INVESTIGATION
- Human XCR1+Dendritic Cells Derived In Vitro from CD34+Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells
- (2014) Sreekumar Balan et al. JOURNAL OF IMMUNOLOGY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Harnessing Human Cross-Presenting CLEC9A+XCR1+ Dendritic Cells for Immunotherapy
- (2014) Kirsteen M. Tullett et al. Frontiers in Immunology
- Cytotoxic and Proinflammatory CD8 + T Lymphocytes Promote Development of Vulnerable Atherosclerotic Plaques in ApoE-Deficient Mice
- (2013) Tin Kyaw et al. CIRCULATION
- Dendritic cell-based nanovaccines for cancer immunotherapy
- (2013) Leonie E Paulis et al. CURRENT OPINION IN IMMUNOLOGY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Immune system targeting by biodegradable nanoparticles for cancer vaccines
- (2013) Joana M. Silva et al. JOURNAL OF CONTROLLED RELEASE
- Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
- (2013) J. Tel et al. JOURNAL OF IMMUNOLOGY
- The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
- (2013) Claudia C. Preston et al. PLoS One
- Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
- (2013) Martin K. Hunn et al. OncoImmunology
- Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- From crucial to negligible: Functional CD8+T-cell responses and their dependence on CD4+T-cell help
- (2012) Melanie Wiesel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Consequences of direct and indirect activation of dendritic cells on antigen presentation: Functional implications and clinical considerations
- (2012) Javier Vega-Ramos et al. MOLECULAR IMMUNOLOGY
- NKT-cell-based immunotherapies in clinical trials
- (2011) Mark A. Exley et al. CLINICAL IMMUNOLOGY
- Harnessing natural killer T (NKT) cells in human myeloma: Progress and challenges
- (2011) Madhav V. Dhodapkar et al. CLINICAL IMMUNOLOGY
- Novel Highly Sensitive IL-10- -Lactamase Reporter Mouse Reveals Cells of the Innate Immune System as a Substantial Source of IL-10 In Vivo
- (2011) H. Bouabe et al. JOURNAL OF IMMUNOLOGY
- Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells
- (2011) Luis J. Cruz et al. MOLECULAR PHARMACEUTICS
- Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection
- (2010) Famke L. Schneiders et al. CLINICAL IMMUNOLOGY
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Therapeutic cancer vaccines: are we there yet?
- (2010) Christopher A. Klebanoff et al. IMMUNOLOGICAL REVIEWS
- Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
- (2010) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+dendritic cells
- (2010) Karine Crozat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+cells as homologues of mouse CD8+dendritic cells
- (2010) Annabell Bachem et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of human DNGR-1+BDCA3+leukocytes as putative equivalents of mouse CD8α+dendritic cells
- (2010) Lionel Franz Poulin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs
- (2010) Verena Semmling et al. NATURE IMMUNOLOGY
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
- (2008) David Sancho et al. JOURNAL OF CLINICAL INVESTIGATION
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now